‘We have to be more aggressive in treating our patients,’ Howard S. Weintraub, MD, a Clinical and cardiologist Associate Professor of Medicine at NYU Medical School, said. ‘This involves individualized testing and early intervention.’ Related StoriesBariatric surgery improves pounds, metabolic health and standard of living in adolescents after 3 yearsNew Cleveland Clinic study shows bariatric medical procedures is safe choice for managing type 2 diabetes in over weight or mildly obese patientsStudy discovers high prevalence of dehydration in the elderly living in UK care homesWeintraub suggested that while gathering a patient’s blood sugar data is essential, assessing their results on an individual basis is crucial.Following the effective close of seed funding in late 2013, Abeona is increasing funds to progress its gene therapy-based clinical programs for both Sanfilippo Syndrome type A and B. Phase I/II scientific trials for both illnesses are anticipated to begin in 2014. Sanfilippo Syndrome is normally a deadly genetic disease resulting from the body's inability to properly breakdown certain sugars. Symptoms often come in the first yr of life, and the disease causes progressive muscular and cognitive decline in kids after the age group of two. There is no cure and currently no approved treatments for Sanfilippo Syndrome. Related StoriesPerisylvian polymicrogyria gene foundApoE4-carrying guys with Alzheimer's disease at risk of mind bleedsResearchers identify tumor suppressor genes that get subset of melanomas It really is so exciting to observe this groundbreaking science consider another critical step forward towards getting this treatment to children, said Cara O'Neill MD, whose SavingEliza.com campaign has gathered international attention previously month for this disease and their individual advocate group, Get rid of Sanfilippo Foundation .